2.54
-0.52(-16.99%)
Currency In USD
| Previous Close | 3.06 |
| Open | 2.88 |
| Day High | 2.88 |
| Day Low | 2.47 |
| 52-Week High | 6.28 |
| 52-Week Low | 1.91 |
| Volume | 356,971 |
| Average Volume | 109,685 |
| Market Cap | 14.96M |
| PE | -1.14 |
| EPS | -2.22 |
| Moving Average 50 Days | 2.88 |
| Moving Average 200 Days | 3.25 |
| Change | -0.52 |
If you invested $1000 in Vivos Therapeutics, Inc. (VVOS) since IPO date, it would be worth $11.3 as of May 18, 2025 at a share price of $2.54. Whereas If you bought $1000 worth of Vivos Therapeutics, Inc. (VVOS) shares 3 years ago, it would be worth $72.06 as of May 18, 2025 at a share price of $2.54.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call
GlobeNewswire Inc.
May 14, 2025 1:15 PM GMT
Call Scheduled for Thursday, May 15, 2025 at 5:00 pm ETLITTLETON, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the develo
Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada
GlobeNewswire Inc.
Apr 16, 2025 12:30 PM GMT
By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to close later this quarter or in the third quarter LITTL
Vivos Therapeutics Schedules Release of Full Year 2024 Financial Results and Conference Call
GlobeNewswire Inc.
Mar 28, 2025 12:30 PM GMT
Call Scheduled for Monday, March 31, 2025 at 5:00 pm ETLITTLETON, Colo., March 28, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the deve